Evidence map›Paper›PMID 27294376›Full record

ArticleJournal of clinical immunology2016

Activated PI3-kinase δ Syndrome: Long-term Follow-up after Cord Blood Transplantation.

Antony Ceraulo, Christophe Malcus, Anne Durandy, Capucine Picard, Yves Bertrand

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Antony CerauloDepartment of Pediatric Oncology and Hematology, Institut d'Hématologie et d'Oncologie Pédiatrique, 1, place du Pr Joseph Renaut, 69008, Lyon, France. antony.ceraulo@chu-lyon.fr.ORCID 0000-0002-4995-1494
Christophe MalcusDepartment of Immunology, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, F-69008, France.
Anne DurandyCenter for Primary Immunodeficiencies (CEDI), Assistance Publique-Hôpitaux de Paris, Necker Children's Hospital, F-75015, Paris, France.
Capucine PicardCenter for Primary Immunodeficiencies (CEDI), Assistance Publique-Hôpitaux de Paris, Necker Children's Hospital, F-75015, Paris, France.
Yves BertrandDepartment of Pediatric Oncology and Hematology, Institut d'Hématologie et d'Oncologie Pédiatrique, 1, place du Pr Joseph Renaut, 69008, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationChildClass I Phosphatidylinositol 3-KinasesFetal BloodFollow-Up StudiesHumansImmunologic Deficiency SyndromesMalePrimary Immunodeficiency DiseasesTime FactorsClass I Phosphatidylinositol 3-KinasesPIK3CD protein, human

Identifiers

PMID27294376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.